FASN and neoplasm: A pivotal mediator of this enhanced lipogenesis is fatty acid synthase (FASN), an enzyme responsible for catalyzing the synthesis of long-chain fatty acids, whose overexpression has been associated with increased tumor proliferation and poor clinical outcomes (67).